KMT2A and acute myeloid leukemia: To identify the DE genes associated with the NRASG12D and NRASG12V mutations, we used previously published RNA-seq data (GSE115911) from THP-1 cells, which is an AML cell line characterized by an MLL-AF9 fusion and a heterozygous NRASG12D mutation, and B11 cells, a THP-1-derived cell line with the NRASG12D mutation replaced by a dox-inducible NRASG12V mutation [8].